Clinical research grants

The SFO Stem cells and Regenerative medicine announces two research grants for clinical and translational research within the area of stem cells, regenerative medicine and cellular therapies.

These grants aim at supporting clinically active physicians, who have both a MD and a PhD degree and are affiliated 100% to SLL and KI at the time of starting the project. During 2018, at least one of these grants will be awarded to a candidate who is within 12 years after obtaining PhD degree, while one is open to all candidates (time for parental leave, military service, and medical specialty training can be deducted). During the period of research support, the applicant should perform clinical work 20-50% of full time. Priority will be given to high quality clinical projects or translational projects with a clear clinical potential.  Examples encompass, however are not restricted to, clinical trials, development of ATMP products or other essential steps for planned clinical trials, correlative biological studies for clinical trials, and diagnostic and biomarker studies. All should have relevance to the field.

Eligible projects will be supported for up to 1MSEK/year for 3 years. Grants can be used to cover salaries, running cost, equipment and administrative costs. Indirect costs for the research project must not exceed the INDI level at the receiving KI department. Starting date for grants is June 1st, 2018. However, within an active recruitment process, the starting date could be delayed to December 1st, 2018 at the latest. A researcher is limited to submit one application for research grants or clinical research grants.

Proposals will undergo external evaluation and will be ranked by international experts in the field. Final decisions will be taken by the SFO Steering committee.

Eligible to apply

Applicants should have a PhD and an MD degree and be affiliated 100% to SLL and KI at the project start. Clinical researchers in the process of being recruited to SLL / KI and who will be employed at the latest December 1st, 2018 are also eligible, but will require a detailed letter of support by the chairs of the receiving institution and clinical department. A final decision about support will require that the applicant has started his or her employment at KI/K. Grants will be transferred to the KI department. The proposed research program should have relevance for the field of stem cells and regenerative medicine. Applicants who received SFO Stem Cells and Regenerative Medicine research grants in 2017 are not eligible to apply.

Relevance

Stem cells play an important role in the development of tissues, for maintenance and regeneration of tissues in adulthood, and for development and progression of disease. Research in this field is rapidly expanding our understanding of these processes. Stem cell therapies are established in clinical medicine for malignant as well as for non-malignant conditions and novel therapies are continuously developed and entered in preclinical and clinical trials. Research projects with relevance for the above-described fields are eligible for support from this strategic research area.

Evaluation criteria and weights

Evaluation of quality and feasibility of the project 25%

5 = Outstanding

4 = Excellent

3 = Very good 

2 =Good

1 = Insufficient

 

Evaluation of the quality and merits of the scientist 25%. For junior applicants evaluation of the applicant´s potential to start an independent and successful line of clinical / translational research 25%

5 = Outstanding

4 = Excellent

3 = Very good 

2 =Good

1 = Insufficient

 

Evaluation of the originality of the project 25%

5 = Outstanding

4 = Excellent

3 = Very good 

2 =Good

1 = Insufficient

 

Clinical relevance 25%, please note that score 1 will make the application ineligible for this call.

5 = Outstanding

3 = Very good 

1 = Insufficient

Application

Each application must be supported both by the head of the KI department and the clinical department, who will thereby ascertain that the applicant holds or will hold a 100% position at SLL/KI. If several departments are involved, each head of department should support the application.

  • Project description (6 pages, Times roman, 12 points, single space, 2 cm margin), covering: Summary (limit 200 words), Objectives, Introduction, Preliminary results, Experimental plan, Significance for the field and references.
  • CV, max 2 pages. Mark whether within 12 years from PhD
  • List of publications, highlighting the 10 most relevant publications of the main applicant
  • Budget description
The application should be submitted in one pdf file to Sri Sahlin, Karolinska Institutet (Sri.Sahlin@ki.se)
Application deadline: January 15th, 2018
Decisions will be announced before May 1st, 2018